Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling

Hsin Yuan Cheng, Anping Dong, Manikandan Panchatcharam, Paul Mueller, Fanmuyi Yang, Zhenyu Li, Gordon Mills, Jerold Chun, Andrew J. Morris, Susan S. Smyth

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective-: Lysophosphatidic acid (LPA) is a bioactive lipid molecule produced by the plasma lysophospholipase D enzyme autotaxin that is present at ≥100 nmol/L in plasma. Local administration of LPA promotes systemic arterial remodeling in rodents. To determine whether LPA contributes to remodeling of the pulmonary vasculature, we examined responses in mice with alterations in LPA signaling and metabolism. Methods and Results-: Enpp2 +/- mice, which are heterozygous for the autotaxin-encoding gene and which have reduced expression of autotaxin/lysophospholipase D and approximately half normal plasma LPA, were hyperresponsive to hypoxia-induced vasoconstriction and remodeling, as evidenced by the development of higher right ventricular (RV) systolic pressure, greater decline in peak flow velocity across the pulmonary valve, and a higher percentage of muscularized arterioles. Mice lacking LPA 1 and LPA 2, 2 LPA receptors abundantly expressed in the vasculature, also had enhanced hypoxia-induced pulmonary remodeling. With age, Lpar1 -/-2 -/- mice spontaneously developed elevated RV systolic pressure and RV hypertrophy that was not observed in Lpar1 -/- mice or Lpar2 -/- mice. Expression of endothelin-1, a potent vasoconstrictor, was elevated in lungs of Lpar1 -/-2 -/- mice, and expression of endothelinB receptor, which promotes vasodilation and clears endothelin, was reduced in Enpp2 +/- and Lpar1 -/-2 -/- mice. Conclusion-: Our findings indicate that LPA may negatively regulate pulmonary vascular pressure through LPA 1 and LPA 2 receptors and that in the absence of LPA signaling, upregulation in the endothelin system favors remodeling.

Original languageEnglish (US)
Pages (from-to)24-32
Number of pages9
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Lung
Lysophosphatidic Acid Receptors
Endothelins
Ventricular Pressure
4 alpha-glucanotransferase
Hypoxia
lysophosphatidic acid
Blood Pressure
Right Ventricular Hypertrophy
Pulmonary Valve
Arterioles
Vasoconstrictor Agents
Endothelin-1
Vasoconstriction
Vasodilation
Blood Vessels
Rodentia
Up-Regulation
Lipids
Pressure

Keywords

  • autotaxin
  • lipids
  • lysophospahtidic acid
  • pulmonary artery
  • pulmonary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. / Cheng, Hsin Yuan; Dong, Anping; Panchatcharam, Manikandan; Mueller, Paul; Yang, Fanmuyi; Li, Zhenyu; Mills, Gordon; Chun, Jerold; Morris, Andrew J.; Smyth, Susan S.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, No. 1, 01.01.2012, p. 24-32.

Research output: Contribution to journalArticle

Cheng, HY, Dong, A, Panchatcharam, M, Mueller, P, Yang, F, Li, Z, Mills, G, Chun, J, Morris, AJ & Smyth, SS 2012, 'Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 1, pp. 24-32. https://doi.org/10.1161/ATVBAHA.111.234708
Cheng, Hsin Yuan ; Dong, Anping ; Panchatcharam, Manikandan ; Mueller, Paul ; Yang, Fanmuyi ; Li, Zhenyu ; Mills, Gordon ; Chun, Jerold ; Morris, Andrew J. ; Smyth, Susan S. / Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2012 ; Vol. 32, No. 1. pp. 24-32.
@article{7f2a91eb2ebe4dc3b1727f0d8df6ad47,
title = "Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling",
abstract = "Objective-: Lysophosphatidic acid (LPA) is a bioactive lipid molecule produced by the plasma lysophospholipase D enzyme autotaxin that is present at ≥100 nmol/L in plasma. Local administration of LPA promotes systemic arterial remodeling in rodents. To determine whether LPA contributes to remodeling of the pulmonary vasculature, we examined responses in mice with alterations in LPA signaling and metabolism. Methods and Results-: Enpp2 +/- mice, which are heterozygous for the autotaxin-encoding gene and which have reduced expression of autotaxin/lysophospholipase D and approximately half normal plasma LPA, were hyperresponsive to hypoxia-induced vasoconstriction and remodeling, as evidenced by the development of higher right ventricular (RV) systolic pressure, greater decline in peak flow velocity across the pulmonary valve, and a higher percentage of muscularized arterioles. Mice lacking LPA 1 and LPA 2, 2 LPA receptors abundantly expressed in the vasculature, also had enhanced hypoxia-induced pulmonary remodeling. With age, Lpar1 -/-2 -/- mice spontaneously developed elevated RV systolic pressure and RV hypertrophy that was not observed in Lpar1 -/- mice or Lpar2 -/- mice. Expression of endothelin-1, a potent vasoconstrictor, was elevated in lungs of Lpar1 -/-2 -/- mice, and expression of endothelinB receptor, which promotes vasodilation and clears endothelin, was reduced in Enpp2 +/- and Lpar1 -/-2 -/- mice. Conclusion-: Our findings indicate that LPA may negatively regulate pulmonary vascular pressure through LPA 1 and LPA 2 receptors and that in the absence of LPA signaling, upregulation in the endothelin system favors remodeling.",
keywords = "autotaxin, lipids, lysophospahtidic acid, pulmonary artery, pulmonary hypertension",
author = "Cheng, {Hsin Yuan} and Anping Dong and Manikandan Panchatcharam and Paul Mueller and Fanmuyi Yang and Zhenyu Li and Gordon Mills and Jerold Chun and Morris, {Andrew J.} and Smyth, {Susan S.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1161/ATVBAHA.111.234708",
language = "English (US)",
volume = "32",
pages = "24--32",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling

AU - Cheng, Hsin Yuan

AU - Dong, Anping

AU - Panchatcharam, Manikandan

AU - Mueller, Paul

AU - Yang, Fanmuyi

AU - Li, Zhenyu

AU - Mills, Gordon

AU - Chun, Jerold

AU - Morris, Andrew J.

AU - Smyth, Susan S.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective-: Lysophosphatidic acid (LPA) is a bioactive lipid molecule produced by the plasma lysophospholipase D enzyme autotaxin that is present at ≥100 nmol/L in plasma. Local administration of LPA promotes systemic arterial remodeling in rodents. To determine whether LPA contributes to remodeling of the pulmonary vasculature, we examined responses in mice with alterations in LPA signaling and metabolism. Methods and Results-: Enpp2 +/- mice, which are heterozygous for the autotaxin-encoding gene and which have reduced expression of autotaxin/lysophospholipase D and approximately half normal plasma LPA, were hyperresponsive to hypoxia-induced vasoconstriction and remodeling, as evidenced by the development of higher right ventricular (RV) systolic pressure, greater decline in peak flow velocity across the pulmonary valve, and a higher percentage of muscularized arterioles. Mice lacking LPA 1 and LPA 2, 2 LPA receptors abundantly expressed in the vasculature, also had enhanced hypoxia-induced pulmonary remodeling. With age, Lpar1 -/-2 -/- mice spontaneously developed elevated RV systolic pressure and RV hypertrophy that was not observed in Lpar1 -/- mice or Lpar2 -/- mice. Expression of endothelin-1, a potent vasoconstrictor, was elevated in lungs of Lpar1 -/-2 -/- mice, and expression of endothelinB receptor, which promotes vasodilation and clears endothelin, was reduced in Enpp2 +/- and Lpar1 -/-2 -/- mice. Conclusion-: Our findings indicate that LPA may negatively regulate pulmonary vascular pressure through LPA 1 and LPA 2 receptors and that in the absence of LPA signaling, upregulation in the endothelin system favors remodeling.

AB - Objective-: Lysophosphatidic acid (LPA) is a bioactive lipid molecule produced by the plasma lysophospholipase D enzyme autotaxin that is present at ≥100 nmol/L in plasma. Local administration of LPA promotes systemic arterial remodeling in rodents. To determine whether LPA contributes to remodeling of the pulmonary vasculature, we examined responses in mice with alterations in LPA signaling and metabolism. Methods and Results-: Enpp2 +/- mice, which are heterozygous for the autotaxin-encoding gene and which have reduced expression of autotaxin/lysophospholipase D and approximately half normal plasma LPA, were hyperresponsive to hypoxia-induced vasoconstriction and remodeling, as evidenced by the development of higher right ventricular (RV) systolic pressure, greater decline in peak flow velocity across the pulmonary valve, and a higher percentage of muscularized arterioles. Mice lacking LPA 1 and LPA 2, 2 LPA receptors abundantly expressed in the vasculature, also had enhanced hypoxia-induced pulmonary remodeling. With age, Lpar1 -/-2 -/- mice spontaneously developed elevated RV systolic pressure and RV hypertrophy that was not observed in Lpar1 -/- mice or Lpar2 -/- mice. Expression of endothelin-1, a potent vasoconstrictor, was elevated in lungs of Lpar1 -/-2 -/- mice, and expression of endothelinB receptor, which promotes vasodilation and clears endothelin, was reduced in Enpp2 +/- and Lpar1 -/-2 -/- mice. Conclusion-: Our findings indicate that LPA may negatively regulate pulmonary vascular pressure through LPA 1 and LPA 2 receptors and that in the absence of LPA signaling, upregulation in the endothelin system favors remodeling.

KW - autotaxin

KW - lipids

KW - lysophospahtidic acid

KW - pulmonary artery

KW - pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=83655163759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655163759&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.111.234708

DO - 10.1161/ATVBAHA.111.234708

M3 - Article

VL - 32

SP - 24

EP - 32

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 1

ER -